Catalyst Pharmaceuticals Inc
Most Recent
Zosano Pharma’s Positive Non-Clinical Trial Results
Today, Zosano Pharma is trading at a stock price of $4.38, which represents ~5.92% growth from its closing price of $4.14 yesterday.
Point72 Asset Management lowers its position in Shutterfly
Shutterfly generates the majority of its revenues from professionally bound photo books, greeting cards, personalized calendars, and other photo-based merchandise.
Point72 Asset Management lowers position in Clearwater Paper
Clearwater Paper Corporation is a leading North American producer of private label tissue and paperboard products.
Point72 increases its position in Walter Investment Management
Walter Investment Management is a fee-based services provider to the residential mortgage industry.
Point72 Asset Management adds position in Catalyst Pharmaceutical
Catalyst Pharmaceutical is a development-stage biopharmaceutical company that develops therapies for rare neuromuscular and neurological diseases.
Point72 Asset Management begins position in Jones Energy
Jones Energy is an independent oil and gas company engaged in the exploration, development, production, and acquisition of oil and natural gas properties.